Thermo Fisher Scientific (NYSE:TMO) is expanding its presence in proteomic biomarker analytics and immuno-oncology diagnostics, according to recent industry reports. Sector intelligence points to the ...
Original Image Link
Source:finance.yahoo.com
Original Image Link
Source:finance.yahoo.com
Posted: 2026-10-16 05:00:00









